Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
We recommend always consulting your health status and any substances that might be influencing your conditions with a healthcare professional
However, these cardiovascular applications require particularly careful consideration given the potential risks associated with promoting angiogenesis in patients who may have undiagnosed malignancies or other conditions where angiogenesis promotion could be detrimental
Hematological abnormalities
AHK-Cu is not FDA-approved for human therapeutic use and is sold exclusively as a research chemical for in-vitro laboratory studies and qualified animal research models
